194 related articles for article (PubMed ID: 36987818)
1. An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations.
Tarricone R; Banks H; Ciani O; Brouwer W; Drummond MF; Leidl R; Martelli N; Sampietro-Colom L; Taylor RS
Expert Rev Med Devices; 2023 Apr; 20(4):259-271. PubMed ID: 36987818
[TBL] [Abstract][Full Text] [Related]
2. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
3. Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective.
Tarricone R; Ciani O; Torbica A; Brouwer W; Chaloutsos G; Drummond MF; Martelli N; Persson U; Leidl R; Levin L; Sampietro-Colom L; Taylor RS
Expert Rev Med Devices; 2020 Oct; 17(10):993-1006. PubMed ID: 32975149
[TBL] [Abstract][Full Text] [Related]
4. Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies.
Tarricone R; Amatucci F; Armeni P; Banks H; Borsoi L; Callea G; Ciani O; Costa F; Federici C; Torbica A; Marletta M
Health Policy; 2021 May; 125(5):602-608. PubMed ID: 33820679
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the renewed European Medical Device Regulations in the frame of the non - EU regulatory landscape during the COVID facilitated change.
Kanti SPY; Csóka I; Adalbert L; Jójárt-Laczkovich O
J Pharm Sci; 2022 Oct; 111(10):2674-2686. PubMed ID: 35872025
[TBL] [Abstract][Full Text] [Related]
6. Different regulatory framework for medical devices and drugs in the European Union: Impact on clinical research and health technology assessments.
Albuquerque de Almeida F; Ricardo M
Int J Health Plann Manage; 2023 Sep; 38(5):1420-1434. PubMed ID: 37316973
[TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review.
Beck A; Retèl VP; Bhairosing PA; van den Brekel M; van Harten WH
Health Policy; 2019 Dec; 123(12):1185-1198. PubMed ID: 31718855
[TBL] [Abstract][Full Text] [Related]
8. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments.
Ciani O; Wilcher B; van Giessen A; Taylor RS
Health Econ; 2017 Feb; 26 Suppl 1():13-29. PubMed ID: 28139087
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the design and implementation of an Early Feasibility Studies program for medical devices in the European Union.
Callea G; Federici C; Freddi R; Tarricone R
Expert Rev Med Devices; 2022 Apr; 19(4):315-325. PubMed ID: 35579009
[TBL] [Abstract][Full Text] [Related]
10. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
[TBL] [Abstract][Full Text] [Related]
11. How does medical device regulation perform in the United States and the European union? A systematic review.
Kramer DB; Xu S; Kesselheim AS
PLoS Med; 2012; 9(7):e1001276. PubMed ID: 22912563
[TBL] [Abstract][Full Text] [Related]
12. HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT FOR THE ADOPTION OF INNOVATIVE MEDICAL DEVICES WITHIN FRENCH HOSPITALS: OPPORTUNITIES AND CHALLENGES FOR INDUSTRY.
Dutot C; Mercier G; Borget I; de Sauvebeuf C; Martelli N
Int J Technol Assess Health Care; 2017 Jan; 33(2):297-302. PubMed ID: 28578711
[TBL] [Abstract][Full Text] [Related]
13. EU and member state medical devices regulation.
Altenstetter C
Int J Technol Assess Health Care; 2003; 19(1):228-48. PubMed ID: 12701954
[TBL] [Abstract][Full Text] [Related]
14. Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges.
Daubner-Bendes R; Kovács S; Niewada M; Huic M; Drummond M; Ciani O; Blankart CR; Mandrik O; Torbica A; Yfantopoulos J; Petrova G; Holownia-Voloskova M; Taylor RS; Al M; Piniazhko O; Lorenzovici L; Tarricone R; Zemplényi A; Kaló Z
Front Public Health; 2020; 8():612410. PubMed ID: 33490024
[No Abstract] [Full Text] [Related]
15. The novelties of the regulation on health technology assessment, a key achievement for the European union health policies.
Pisapia A; Banfi G; Tomaiuolo R
Clin Chem Lab Med; 2022 Jul; 60(8):1160-1163. PubMed ID: 35624072
[TBL] [Abstract][Full Text] [Related]
16. Implementing the new European Regulations on medical devices-clinical responsibilities for evidence-based practice: a report from the Regulatory Affairs Committee of the European Society of Cardiology.
Fraser AG; Byrne RA; Kautzner J; Butchart EG; Szymański P; Leggeri I; de Boer RA; Caiani EG; Van de Werf F; Vardas PE; Badimon L
Eur Heart J; 2020 Jul; 41(27):2589-2596. PubMed ID: 32484542
[TBL] [Abstract][Full Text] [Related]
17. Health technology assessment of medical devices: a survey of non-European union agencies.
Ciani O; Wilcher B; Blankart CR; Hatz M; Rupel VP; Erker RS; Varabyova Y; Taylor RS
Int J Technol Assess Health Care; 2015 Jan; 31(3):154-65. PubMed ID: 26044729
[TBL] [Abstract][Full Text] [Related]
18. Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries.
Wilking N; Bucsics A; Kandolf Sekulovic L; Kobelt G; Laslop A; Makaroff L; Roediger A; Zielinski C
ESMO Open; 2019; 4(6):e000550. PubMed ID: 31798977
[TBL] [Abstract][Full Text] [Related]
19. Early market access of cancer drugs in the EU.
Martinalbo J; Bowen D; Camarero J; Chapelin M; Démolis P; Foggi P; Jonsson B; Llinares J; Moreau A; O'Connor D; Oliveira J; Vamvakas S; Pignatti F
Ann Oncol; 2016 Jan; 27(1):96-105. PubMed ID: 26487583
[TBL] [Abstract][Full Text] [Related]
20. [Policy developments of health technology assessment in the European Union].
Baran-Kooiker A; Czech M; Hołownia-Voloskova M
Postepy Biochem; 2019 Nov; 65(4):319-321. PubMed ID: 31945287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
